Mini symposium - Evolution of the biosimilar regulatory landscape - Challenges and opportunities

Tuesday 15th of April 2014
SY13, 1 hours

Chair: Anita O"connor (USA)

Meeting room 212 & 213

09.00 – 09.30      Biologicals and biosimilars, what’s in a name?
(TU-06-01) Paul Declerck, KU Leuven, Belgium

09.30 – 10.00     Regulation of Biosimilars: Considerations in the Development of Biosimilars in an Evolving Landscape
(TU-06-02) Scott Anderson, Pfizer, San Diego, USA